Rallybio Corporation
USD16.12
+0.06 (+0.37%)
CEO
Stephen Uden
IPO Date
2021-07-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.17
Prev. Close
$16.06
Day Low
$15.86
Day High
$16.48
52W Low
$2.55
52W High
$17.57
Market Cap
$0.09B
Volume
0.00M
| -0.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -70.2% | -64.5% | 0.00 | 12.39 | -1.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -39.4% | -36.9% | 0.00 | 16.71 | -3.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -26.8% | -25.8% | 0.00 | 27.61 | -6.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -19.4% | -18.6% | 0.00 | 24.18 | -11.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -104.5% | -81.6% | 0.00 | 5.50 | -17.8 |
| -1.2 |
| 30 Sept 2025 | Q3 | 100.0% | 7554.7% | 25.4% | 23.7% | 0.00 | 14.74 | 0.4 |
| 30 Jun 2025 | Q2 | 100.0% | -4576.9% | -21.1% | -19.0% | 0.00 | 9.98 | -0.4 |
| 31 Mar 2025 | Q1 | 100.0% | -4452.4% | -17.5% | -16.3% | 0.00 | 14.68 | -0.8 |
| 31 Dec 2024 | Q4 | 21.1% | -29063.2% | -17.9% | -16.2% | 0.00 | 10.87 | -1.0 |
| 30 Sept 2024 | Q3 | 100.0% | -3834.8% | -16.2% | -14.5% | 0.00 | 9.55 | -1.1 |
| 30 Jun 2024 | Q2 | 88.6% | -5430.1% | -20.3% | -17.6% | 0.00 | 7.52 | -0.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -21.3% | -19.2% | 0.00 | 9.77 | -1.0 |
| 31 Dec 2023 | Q4 | 50.0% | -8878.1% | -19.1% | -17.5% | 0.00 | 12.39 | -1.2 |